Pyrano[3,2-c]quinoline Derivatives as New Class of α-glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in vitro Biological Evaluation and Kinetic Study

MLA

Somaye Imanparast, et al. “Pyrano[3,2-c]Quinoline Derivatives as New Class of α-Glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in Vitro Biological Evaluation and Kinetic Study.” Medicinal Chemistry (Shariqah (United Arab Emirates)), vol. 15, no. 1, Dec. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....de309dbd5c0a184172f9d053b7032b62&authtype=sso&custid=ns315887.

APA

Somaye Imanparast, Zahra Heydari, Mohammad Ali Faramarzi, Mohammad Mahdavi, Bagher Larijani, Maryam Mohammadi-Khanaposhtani, & Parviz Rashidi Ranjbar. (2017). Pyrano[3,2-c]quinoline Derivatives as New Class of α-glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in vitro Biological Evaluation and Kinetic Study. Medicinal Chemistry (Shariqah (United Arab Emirates)), 15(1).

Chicago

Somaye Imanparast, Zahra Heydari, Mohammad Ali Faramarzi, Mohammad Mahdavi, Bagher Larijani, Maryam Mohammadi-Khanaposhtani, and Parviz Rashidi Ranjbar. 2017. “Pyrano[3,2-c]Quinoline Derivatives as New Class of α-Glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in Vitro Biological Evaluation and Kinetic Study.” Medicinal Chemistry (Shariqah (United Arab Emirates)) 15 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....de309dbd5c0a184172f9d053b7032b62&authtype=sso&custid=ns315887.